Age-related Vision Dysfunction Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Age-related Vision Dysfunction Market is segmented By Disease (Age-related Macular Degeneration, Diabetic Retinopathy, Cataracts, Glaucoma, Presbyopia), By Treatment (Anti-angiogenic Drugs, Laser Therapy, Photodynamic Laser Therapy, Minimally Invasive Glaucoma Surgery), By Product (Prescription Drugs, Surgical Devices), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned.
Age-related Vision Dysfunction Market Size
Market Size in USD
CAGR6.1%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 6.1% |
| Market Concentration | High |
| Major Players | Novartis, Regeneron Pharmaceuticals, Roche, Bayer, Alcon |
please let us know !
Age-related Vision Dysfunction Market Analysis
The age-related vision dysfunction market is estimated to be valued at USD 3.8 Bn in 2024 and is expected to reach USD 5.75 Bn by 2031, growing at a compound annual growth rate (CAGR) of 6.1% from 2024 to 2031. Factors such as the increasing life expectancies and burgeoning senior populations in developed nations are contributing to the growing incidence of vision problems arising from normal aging and age-related diseases. Additionally, improved access to diagnostic technologies and treatments is aiding to the expansion of age-related vision dysfunction market.